Trv Gp Iv, LLC Fulcrum Therapeutics, Inc. Transaction History
Trv Gp Iv, LLC
- $202 Million
- Q2 2024
A detailed history of Trv Gp Iv, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Trv Gp Iv, LLC holds 2,343,154 shares of FULC stock, worth $8.83 Million. This represents 7.18% of its overall portfolio holdings.
Number of Shares
2,343,154
Previous 2,343,154
-0.0%
Holding current value
$8.83 Million
Previous $22.1 Million
34.32%
% of portfolio
7.18%
Previous 10.72%
Shares
1 transactions
Others Institutions Holding FULC
# of Institutions
135Shares Held
59.5MCall Options Held
4.32MPut Options Held
307K-
Ra Capital Management, L.P. Boston, MA11.6MShares$43.8 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$22 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$18.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$11.6 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$11.2 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $196M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...